Alan P. Venook

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Mapping the Anatomical Landscape of Colorectal Tumours: Location-Specific Efficacy of Anti-Epidermal Growth Factor Receptor Antibodies: Pooled Analysis of Randomised Trials

  European Journal of Cancer · 2026-06-01

• Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer

  UNC Libraries · 2026-04-18

• Abstract 1011: Correlation of mitophagy related genes expression and clinical outcome in metastatic colorectal cancer patients enrolled in CALGB (Alliance)/SWOG 80405

  Cancer Research · 2026-04-03

• Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction

  JHEP Reports · 2026-03-12

• Shifts in the human gut microbiome during cancer chemotherapy are diet-dependentPreprint

  Research Square · 2026-01-08

• Shifts in the human gut microbiome during cancer chemotherapy are diet-dependent

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-12-24

• Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy

  UNC Libraries · 2025-12-09

• Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance)

  ESMO Open · 2025-12-01 · 1 citations

• Supplementary Table S1 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

  2025-11-25

• Supplementary Figure S1 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

  2025-11-25

• Supplementary Figure S2 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

  2025-11-25

• Supplementary Figure S3 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

  2025-11-25

• Supplementary Methods S1 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

  2025-11-25

• Supplementary Table S3 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

  2025-11-25

• Supplementary Table S2 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

  2025-11-25

• Supplementary Table S5 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

  2025-11-25

• Supplementary Table S4 from Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

  2025-11-25

• Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)

  UNC Libraries · 2025-11-18

• 705 Immunosuppressive CD14 ⁺ monocytes are enriched in patients with hepatocellular carcinoma and worse liver function (child-pugh B) and are associated with unfavorable immunotherapy outcomes

  Regular and Young Investigator Award Abstracts · 2025-11-01

• Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study

  European Journal of Cancer · 2025-10-04